Mutations in the exonuclease domains of the POLE and POLD1 genes (present in ~1–2% and <1% of colorectal cancers, respectively) lead to a hypermutated phenotype characterized by defective DNA proofreading [190]. This evidence concerns the gene POLE and colorectal cancer.